Amgen’s Clinical Trial Setback With Colon Cancer Drug, Vectibix

March 23, 2007
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.  More on this from Business Week.
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.  More on this from Business Week.
About the Author

pharmamanufacturing | pharmamanufacturing